Emflaza (Deflazacort Tablets) and Novoeight recombinant
Determining the interaction of Emflaza (Deflazacort Tablets) and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deflazacort
Brand name: Emflaza
Synonyms: Emflaza
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emflaza (Deflazacort Tablets)-Novolin 70/30
- Emflaza (Deflazacort Tablets)-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Emflaza (Deflazacort Tablets)-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Emflaza (Deflazacort Tablets)-Novolin N
- Emflaza (Deflazacort Tablets)-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Emflaza (Deflazacort Tablets)-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Emicizumab
- Novoeight recombinant-Emicizumab-kxwh
- Novoeight recombinant-Emicizumab-kxwh Subcutaneous
- Novoeight recombinant-Emla
- Novoeight recombinant-Emla Topical
- Novoeight recombinant-Emo-Cort Scalp Solution Topical application